CARsgen Therapeutics
Houston, United States· Est. 2014
Our vision is to become a global biopharmaceutical leader that brings innovative and differentiated cell therapies to cancer patients worldwide and makes cancer curable.
Private Company
Total funding raised: $690M
About
Our vision is to become a global biopharmaceutical leader that brings innovative and differentiated cell therapies to cancer patients worldwide and makes cancer curable.
BiologicsCell & Gene Therapy
Funding History
7Total raised:$690M
IPO$150MJun 18, 2021
IPO$150MJun 18, 2021
Series B$140MDec 15, 2019
Series C$100MJun 15, 2019